PSC Partner Media Releases

PSC Partners Announces the First Patient Enrolled Into the WIND-PSC Study, a Global Prospective Cohort to Support the Development of New Treatments for Primary Sclerosing Cholangitis DENVER & TORONTO–(BUSINESS WIRE)–PSC Partners and PSC Partners Canada, both patient-led non-profit organizations supporting education and research in primary sclerosing cholangitis (PSC), announced today the enrollment of the first … Read more

“What the Cell?!” – Scientists and Patients Collaborate to Translate Basic Science to Rare Disease Patient Community DENVER (Colo.) and TORONTO (Ont.) – Patients, their families, clinicians, and scientists gathered recently for an important discussion about primary sclerosing cholangitis (PSC), a rare autoimmune liver disease affecting over 3,000 Canadians, and one in 10,000 people worldwide. … Read more

PSC Partners Seeking a Cure is part of CZI Study DENVER (Colo.) and TORONTO (Ont.) – PSC Partners Seeking a Cure is one of five patient-led rare disease groups that, together with collaborative research teams, were selected for support of four-year research projects aimed at advancing understanding of the fundamental biology underlying their rare inflammatory … Read more

International Nonprofits Join Forces To Raise Awareness For Rare Liver Disease DENVER (Colo.) and TORONTO (Ont.) – Nonprofits worldwide are recognizing Global PSC Awareness Day on October 29, 2022, to increase awareness for the rare liver disease primary sclerosing cholangitis (PSC), which affects approximately one in 10,000 people worldwide. “Awareness about PSC is increasing, but, … Read more